Hypnotic and sleep quality-enhancing properties of kavain in sleep-disturbed rats

J Pharmacol Sci. 2009 Nov;111(3):293-8. doi: 10.1254/jphs.09167fp. Epub 2009 Oct 31.

Abstract

The present study was performed to investigate the effects of kavain on the sleep-wake cycle in comparison with that of rilmazafone and diphenhydramine using sleep-disturbed rats. Electrodes for the electroencephalogram (EEG) and electromyogram (EMG) were implanted into Wistar rats. Total awake time, non-rapid eye movement (non-REM) sleep and rapid eye movement (REM) sleep were measured for 6 h. Kavain and rilmazafone showed a significant shortening in sleep latency, decreased awake time, and increased non-REM sleep time. On the other hand, significant shortening of the sleep latency was observed following the administration of diphenhydramine, while no effects were observed on the awake and non-REM sleep time. Moreover, kavain showed a significant increase in delta activity during non-REM sleep in sleep-disturbed rats, whereas a significant decrease in delta power during non-REM sleep was observed with rilmazafone. These results clearly indicate that kavain is a compound with not only hypnotic effects, but also sleep quality-enhancement effects.

MeSH terms

  • Animals
  • Delta Rhythm / drug effects
  • Diphenhydramine / pharmacology
  • Electroencephalography / drug effects
  • Electromyography / drug effects
  • Hypnotics and Sedatives*
  • Male
  • Pyrones / pharmacology*
  • Pyrones / therapeutic use
  • Rats
  • Rats, Wistar
  • Sleep / drug effects*
  • Sleep Wake Disorders / drug therapy*
  • Triazoles / pharmacology
  • Wakefulness / drug effects

Substances

  • Hypnotics and Sedatives
  • Pyrones
  • Triazoles
  • Diphenhydramine
  • rilmazafone
  • kavain